*Corresponding Author: Dr. Indra Prasad Adhikari, Assistant Professor, Department of Biochemistry, SKS Hospital Medical College & Research Centre, Mathura, Uttar Pradesh, India. Email: harshaladhikari@gmail.com
Background: Hemorrhoidal disease is the most common disease of the anorectal region. Its symptoms are variable, including bleeding, pain, discharge, and itching, which may be troublesome. Treatment options include conservative medical, conventional hemorrhoidectomy (CH), minimally invasive stapled hemorrhoidopexy (SH), and recently, laser hemorrhoidoplasty (LH).
Aim: The aim of this study is to compare SH, CH and LH in the management of second-degree and third-degree piles in terms of postoperative pain, bleeding, incontinence, stenosis, recurrence, and patient satisfaction.
Patients and Methods: Seventy-eight patients who underwent management of hemorrhoids using either LH, SH or CH were assessed. Efficacy and tolerability in terms of postoperative pain, bleeding, incontinence, stenosis, and recurrence were compared.
Results: Lower postoperative pain scores with the need for fewer analgesics were noted after LH, with shorter hospital stay, early return to daily activities, and lower incidence of incontinence, while lower postoperative bleeding incidences and recurrence rates were noted following SH. No incidence of postoperative anal stenosis was found with both procedures, and the overall satisfaction was almost equal.
Conclusion: LH is a simple and safe technique with less postoperative pain, operative time, and hospital stay, but with a higher rate of recurrence, while SH is a more reliable technique with less postoperative bleeding and recurrence, and may be a suitable alternative to conventional hemorrhoidectomy.
Keywords: Hemorrhoids, Laser hemorrhoidoplasty, Stapled hemorrhoidopexy, Conventional hemorrhoidectomy, Postoperative pain, Recurrence.
How to cite this article: Hussan SA, Tripathi DD, Singh R, Adhikari IP. Comparison of various types of surgical management in patients of hemorrhoids. Int J Drug Deliv Technol. 2026;16(7s): 433-441; DOI: 10.25258/ijddt.16.7s.46
Source of support: Nil.
Conflict of interest: None